Legal Counsel
Universal DX
Legal Counsel
Universal DX
Liquid biopsy colorectal cancer detection test
About our Company:
Universal DX, Inc. is an international Company with a highly experienced team focused on cracking cancer’s code. Through our multi-omics and bioinformatics models, we have figured out how to read the disease’s signals in blood with high accuracy to detect cancer in its earliest stages. Starting with a colorectal cancer screening liquid biopsy test, we are building a multi-cancer platform that can identify the unique DNA regions associated with different types of cancers.
Universal DX is seeking an experienced Legal Counsel to support its US business, including its laboratory operations in Dallas, Texas. As part of an international Legal team, you will advise on clinical research, commercial activities and corporate matters, helping the business assess risk and move decisions and agreements forward.
Reporting to the Senior Legal Manager, you will independently manage a varied portfolio of legal matters and negotiations, partnering with US business teams and European colleagues. The role requires sound judgment, practical advice and the ability to recognize when material risks or strategic decisions require escalation.
Why Now?
This is an exciting time to be at Universal DX. We are growing rapidly and starting our US operations by building up our team, starting our lab and business operations, and establishing strategic partnerships.
We are looking for passionate changemakers to be a part of our journey in this expansive time for us.
Liquid biopsy colorectal cancer detection test
Universal Dx offers Signal-C®, a liquid biopsy test for colorectal cancer and advanced adenomas. The test analyzes a blood sample using multi-omics, computational biology, and machine learning to identify cancer signals, achieving 92% sensitivity and 94% specificity. Its collaboration with Quest Diagnostics and planned FDA approval help scale access through a major diagnostic network, differentiating it by scaled distribution and proven accuracy. The goal is to improve early detection, reduce cancer incidence and mortality, and make screening more accessible to the population.
Explore more opportunities at Universal DX